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ObituaryJu¨rg Tschopp (1951–2011)Ju¨rg Tschopp, a wonderful biochemist
and immunologist, died on March 22,
2011 following a skiing tour in
Switzerland. He was 59 years old. The
community is saddened by the loss of
such a noteworthy colleague and a gifted
thinker.
Great scientists come in many varieties
that are characterized by the music they
create as they explore their topics.
Some are best known for a pure melodic
line produced with few instruments, the
focus and simplicity being what makes it
beautiful. Others evoke an early, awe-
inspiring crescendo followed by simpler
themes, an adagio as the last movement
of their careers. Then there are those
who command the entire symphony,
weaving multiple motifs and refrains into
a sublime opus. Ju¨rg was in this latter
category, a conductor composing an
immunological song that never stopped
building.
Ju¨rg Tschopp was born in a village
outside of Basel, Switzerland, and trained
in biophysics at the University of Basel.He came to the United States
in 1980 as a postdoctoral
fellow to work on the com-
plement system at Scripps
Research Institute in La Jolla
with the late Hans J. Mu¨ller-
Eberhard. There he revealed
the polymerizing ability of
C9 that led to lytic pore
formation. He returned to
Switzerland, joining the
faculty in the Department
of Biochemistry at the Uni-
versity of Lausanne, where
he made most of his fun-
damental discoveries. Fol-
lowing his interest in cell
death mechanisms, he
made major contributions to
understanding the mech-
anism of cell-mediated
death by applying bio-
chemistry to the study of
cytotoxic granules of
T cells. His discovery of per-
forin was a pivotal event,
and the subsequent genera-
tion of a perforin-deficient
mouse provided key insightsthat helped usher in the emerging era of
the Fas-mediated cell death model. His
group made many discoveries in the
apoptosis field, including the discovery
of the regulator FLIP, contributing to the
picture of apoptosis that is now part of
any basic curriculum. In the late 1990s in
a collaboration with Kay Hoffman, a bio-
informatics scientist, he seized upon
data mining as a technique for analyzing
the ever-increasing number of DNA
sequences. This became a turning point
in his career, leading to the identification
of several novel members of the TNF
family. Ju¨rg’s true talent derived from
a combination of an advanced under-
standing of protein biochemistry and bio-
informatics and a highly honed intuition
that resulted in a facile ability to link the
biological dots. Following his successes
in the TNF field, he studied the CARD
motifs, teasing apart the rich fabric of
pathogen-recognition systems that form
the core of innate immunity. In 2002, in
his most seminal work, he defined
a multiprotein intracellular complex thatImmunityhe termed the ‘‘inflammasome.’’ He
showed that caspase 1, which is involved
in the processing of IL-1b, is activated by
the NALP3 inflammasome. In recent
years, the plethora of agents found to be
sensed by the inflammasome and related
elements has grown vast, and in fact, Ju¨rg
remarked that perhaps it was unnerving
that so many danger signals were
coupled to the inflammasome. The
Louis-Jeantet Foundation Prize for Medi-
cine in 2008, and the Novartis Prize in
Immunology in 2010, recognized Ju¨rg’s
accomplishments in the fields of
apoptosis and inflammation.
Ju¨rg distinguished himself from many
scientists by venturing into the transla-
tional medicine arena, a place of relatively
few controlled variables. He started three
companies based on his work, and
formed liaisons with the biotechnology
and pharmaceutical sectors to facilitate
clinical translation of his science.
Certainly, his efforts on the BAFF B cell
survival system contributed to the first
approved drug for SLE. His work on the34, April 22inflammasome led to the
hypothesis that IL-1 inhibition
could ameliorate conditions
driven by aberrant danger
sensing, and indeed, clinical
testing has validated this
notion in the settings of gout,
CAPS (cryopyrin-associated
periodic syndromes), and
type 2 diabetes. This advance
is on course to alter current
medical practice.
Asa testimonyofhis skillsas
a professor of philosophy and
science, Ju¨rg’s students and
fellows now populate many
institutions of higher learning
around the world. We are
personally grateful of his fond-
ness for the shores in La Jolla;
he returned several times in
recent years as sabbatical
scholar to impart his fruitful
Swiss philosophy of science
and life. He was always en-
gagedand inspiredbyscience,
andalwaysencouragedexplo-
ration of, and participation
in, the next thought wave., 2011 ª2011 Elsevier Inc. 451
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ObituaryAs a collaborator, he was an honest
gentleman, open and sharing. In his more
private life, he loved his family and Labs
(of the canine variety, that is).
Ju¨rg was also a talented athlete and
excelled in many sports. One of us (J.B.),
as a young postdoctoral fellow at the Bio-
zentrum inBasel, had the opportunity (and
annoyance) of skiing in his wake on many
ski slopes. As a neophyte skier, Jeff still
remembers wondering how Ju¨rg could
have the same perfect form no matter
what the snow conditions. In hindsight,452 Immunity 34, April 22, 2011 ª2011 Elsevwe can see that this gift extended to
his science—regardless of the path or
its complexity, he was able to traverse
the terrain with style, grace, and precision.
While the careers of great scientists can
be described in terms of musical forms,
their personalities can be described in
terms of instruments. Some are domi-
nating and set the tone, like drums or
brass, while others are dependable and
blend into the general melody, like violas.
Ju¨rg was neither of these, nor was he
merely another instrument—he was theier Inc.baton, directingmany of us devoted disci-
ples of science to play on.
The field of science has lost a master
and, for many around the globe, a friend.Jeffrey Browning1 and Carl Ware2,*
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